[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-364836-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-364836-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","apobec3-proteins-from-antiviral-immunity-to-oncogenic-drivers-in-hpv-positive-cancers","APOBEC3 Proteins - From Antiviral Immunity to Oncogenic Drivers in HPV-Positive Cancers","","The human APOBEC superfamily includes eleven cytidine deaminase enzymes, with APOBEC3 members acting in both antiviral defense and cancer development. APOBEC3A and APOBEC3B can mutate viral DNA to inhibit replication, but they also generate somatic mutations within the host genome. Their activity contributes to mutational signatures in more than half of human cancers, with APOBEC3A described as highly mutagenic. APOBEC3B links to HPV-associated carcinogenesis by promoting mutagenesis and tumor progression, and the A3A_B deletion polymorphism is associated with increased A3A expression, mutagenic potential, and cancer risk in susceptible populations.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/apobec3-proteins-from-antiviral-immunity-to-oncogenic-drivers-in-hpv-positive-cancers/364836/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/apobec3-proteins-from-antiviral-immunity-to-oncogenic-drivers-in-hpv-positive-cancers/364836.png","ImageObject",300,407,{"name":42,"@type":43},"Rowan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What dual roles do APOBEC3 enzymes play in human biology?","Question",{"text":63,"@type":64},"APOBEC3 enzymes participate in antiviral immunity by introducing mutations into viral DNA, but their same activity can drive somatic mutations in the host genome, contributing to cancer development.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How are APOBEC3A and APOBEC3B associated with cancer mutational signatures?",{"text":68,"@type":64},"Studies link the mutagenic activities of APOBEC3A and APOBEC3B to mutational signatures seen in over 50% of human cancers, with APOBEC3A characterized as a potent mutagen.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the significance of the A3A_B deletion polymorphism?",{"text":72,"@type":64},"The A3A_B deletion can create a hybrid A3A_B gene, leading to increased A3A expression and enhanced mutagenic potential, which has been associated with elevated cancer risk in populations where it is more prevalent.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},364836,1790204880,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":33,"preview_urls":145},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Review  \nAPOBEC3 Proteins: From Antiviral Immunity to Oncogenic Drivers in HPV-Positive Cancers  \nEliza Pizarro Castilha 1, Rosalba Biondo 2, Kleber Paiva Trugilo 1, Giulia Mariane Fortunato 1, Timothy Robert Fenton 3,4,† and Karen Brajão de Oliveira 1,5, *,†  \nAcademic Editor: Jaquelin P. Dudley  \nReceived: 5 February 2025  \nRevised: 12 March 2025  \nAccepted: 14 March 2025  \nPublished: 18 March 2025  \nCitation: Castilha, E.P.; Biondo, R.; Trugilo, K.P.; Fortunato, G.M.; Fenton, T.R.; Oliveira, K.B.d. APOBEC3 Proteins: From Antiviral Immunity to Oncogenic Drivers in HPV-Positive Cancers. Viruses 2025, 17, 436 . [https://doi.org/10.3390/v17030436](https://doi.org/10.3390/v17030436)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Laboratory of Molecular Genetics and Immunology, Department of Immunology, Parasitology and General Pathology, Center of Biological Sciences, State University of Londrina, Londrina 86057-970, Brazil; [eliza.pizarro.castilha@uel.br](eliza.pizarro.castilha@uel.br) (E.P.C.); [klebertrugilo01@gmail.com](klebertrugilo01@gmail.com) (K.P.T.); [giulia.fortunato@uel.br](giulia.fortunato@uel.br) (G.M.F.)  \n2 Leiden Academic Centre for Drug Research, Analytical Biosciences, Leiden University, P.O. Box 9502, 2311 EZ Leiden, The Netherlands; [r.biondo@lacdr.leidenuniv.nl](r.biondo@lacdr.leidenuniv.nl)  \n3 School of Cancer Sciences, Faculty of Medicine, University of Southampton, University Hospital Southampton, Tremona Road, Southampton SO16 6YD, UK; [t.r.fenton@soton.ac.uk](t.r.fenton@soton.ac.uk)  \n4 Institute for Life Sciences, University of Southampton, University Road, Southampton SO17 1BJ, UK  \n5 Polymorphism Research Laboratory, Department of Immunology, Parasitology and General Pathology, Center of Biological Sciences, State University of Londrina, Londrina 86057-970, Brazil  \n* Correspondence: karen.brajao@uel.br; Tel.: +55-43-3371-5728; Fax: +55-43-3371-4207 † These authors contributed equally to this work.  \nAbstract: The human APOBEC superfamily consists of eleven cytidine deaminase enzymes. Among them, APOBEC3 enzymes play a dual role in antiviral immunity and cancer development. APOBEC3 enzymes, including APOBEC3A (A3A) and APOBEC3B (A3B), induce mutations in viral DNA, effectively inhibiting viral replication but also promoting somatic mutations in the host genome, contributing to cancer development. A3A and A3B are linked to mutational signatures in over 50% of human cancers, with A3A being a potent mutagen. A3B, one of the first APOBEC3 enzymes linked to carcinogenesis, plays a significant role in HPV-associated cancers by driving somatic mutagenesis and tumor progression. The A3A_B deletion polymorphism results in a hybrid A3A_B gene, leading to increased A3A expression and enhanced mutagenic potential. Such polymorphism has been linked to an elevated risk of certain cancers, particularly in populations where it is more prevalent. This review explores the molecular mechanisms of APOBEC3 proteins, highlighting their dual roles in antiviral defense and tumorigenesis. We also discuss the clinical implications of genetic variants, such as the A3A_B polymorphism, mainly in HPV infection and associated cancers, providing a comprehensive understanding of their contributions to both viral restriction and cancer development.  \nKeywords: deamination; APOBEC; cancer; HPV  \n1. Introduction  \nThe apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like (APOBEC) superfamily consists of a group of cytidine deaminase enzymes that play fundamental roles in immunity, metabolism, and the regulation of gene expression. These enzymes catalyze the conversion of cytidines into uridines in single-stranded DNA or","cbCaipWjw9uPpkc9","https://ap.wps.com/l/cbCaipWjw9uPpkc9","pdf",2022336,16,"English","# Abstract\n# 1. Introduction\n## APOBEC superfamily and cytidine deamination\n## APOBEC3 roles in immunity and mobile genetic elements\n## APOBEC3A/APOBEC3B mutagenic activities and cancer signatures\n## Viral manipulation by HPV and implications for tumor initiation and progression","[{\"question\":\"What dual roles do APOBEC3 enzymes play in human biology?\",\"answer\":\"APOBEC3 enzymes participate in antiviral immunity by introducing mutations into viral DNA, but their same activity can drive somatic mutations in the host genome, contributing to cancer development.\"},{\"question\":\"How are APOBEC3A and APOBEC3B associated with cancer mutational signatures?\",\"answer\":\"Studies link the mutagenic activities of APOBEC3A and APOBEC3B to mutational signatures seen in over 50% of human cancers, with APOBEC3A characterized as a potent mutagen.\"},{\"question\":\"What is the significance of the A3A_B deletion polymorphism?\",\"answer\":\"The A3A_B deletion can create a hybrid A3A_B gene, leading to increased A3A expression and enhanced mutagenic potential, which has been associated with elevated cancer risk in populations where it is more prevalent.\"}]","APOBEC3 Proteins - From Antiviral Immunity to Oncogenic Drivers in HPV-Positive Cancers | PDF",1790159191,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d5ddcca619975154511901a7a83926f.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fea11ebdf08fdc2df78d3a6ee499c6f9.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/09b7388760a13d404384d457d864284c.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/839e5dedd97c75200f259281fb24a9af.webp",980,1385]